# Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

Article · Mansoor Raza Mirza, Dana M. Chase, Brian M. Slomovitz, René dePont Christensen, Zoltán Novàk, Destin R. Black, Lucy Gilbert, Sudarshan Kumar Sharma, Giorgio Valabrega, Lisa Michelle Landrum, Lars Hanker, Ashley R. Stuckey, Ingrid A Boere, Michael A. Gold, Annika Auranen, Bhavana Pothuri, David Cibula, Carolyn Kay McCourt, Francesco Raspagliesi, Mark S. Shahin, Sarah E. Gill, Bradley J. Monk, Joseph Buscema, Thomas J. Herzog, Larry J. Copeland and 6 more

- Archive id: doi:10.1056/nejmoa2216334
- Published: 2023-03-27
- Venue: New England Journal of Medicine
- DOI: https://doi.org/10.1056/nejmoa2216334
- PMID: 36972026
- Citations: 882
- Source URL: https://doi.org/10.1056/nejmoa2216334
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cancer Immunotherapy](https://space-kitty.com/topics/cancer-immunotherapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.